GPAT2 and metabolic dysfunction-associated steatotic liver disease: In addition, we also reported upregulation of Gpat2 and Pgc1-α and downregulation of Acot11, Acot13, Gpat4, and Cideb mRNA in E4orf1-Tg mice, which has protective effect against NAFLD development26.